Biomolecules & Therapeutics

The Korean Society of Applied Pharmacology (한국응용약물학회)
권호 표지
DOI QR코드

DOI QR Code

β-Lapachone Exerts Hypnotic Effects via Adenosine A1 Receptor in Mice

  • Do Hyun Lee (Department of Pharmacy, Ajou University) ;
  • Hye Jin Jee (Department of Pharmacy, Ajou University) ;
  • Yi-Sook Jung (Department of Pharmacy, Ajou University)
  • Received : 2024.06.24
  • Accepted : 2024.08.03
  • Published : 2024.09.01
Download PDF
⟨ Previous Next ⟩

Abstract

Sleep is one of the most essential physiological phenomena for maintaining health. Sleep disturbances, such as insomnia, are often accompanied by psychiatric or physical conditions such as impaired attention, anxiety, and stress. Medication used to treat insomnia have concerns about potential side effects with long-term use, so interest in the use of alternative medicine is increasing. In this study, we investigated the hypnotic effects of β-lapachone (β-Lap), a natural naphthoquinone compound, using pentobarbital-induced sleep test, immunohistochemistry, real-time PCR, and western blot in mice. Our results indicated that β-Lap exerts a significant hypnotic effect by showing a decrease in sleep onset latency and an increase in total sleep time in pentobarbital-induced sleep model. The results of c-Fos immunostaining showed that β-Lap decreased neuronal activity in the basal forebrain and lateral hypothalamus, which are wakefulness-promoting brain regions, while increasing in the ventrolateral preoptic nucleus, a sleep-promoting region; all these effects were significantly abolished by 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), an adenosine A1 receptor (A1R) antagonist. Western blot analysis showed that β-Lap increased extracellular signal-regulated kinase phosphorylation and nuclear factor-kappa B translocation from the cytoplasm to the nucleus; these effects were inhibited by DPCPX. Additionally, β-Lap increased the mRNA levels of A1R. Taken together, these results suggest that β-Lap exerts hypnotic effects, potentially through A1R.

Keywords

Acknowledgement

This research was supported by the GRRC program of Gyeonggi province (GRRCAjou2023-B01).

References

  1. Al-Awthan, Y. S., Rauf, A., Rashid, U., Bawazeer, S., Naz, S., Bahattab, O., Bawazeer, S., Muhammad, N., Waggas, D. S., Batiha, G. E., Shariati, M. A., Derkho, M. and Suleria, H. A. R. (2021) Sedative-hypnotic effect and in silico study of dinaphthodiospyrols isolated from Diospyros lotus Linn. Biomed. Pharmacother. 140, 111745.
  2. Alam, M. N., Kumar, S., Rai, S., Methippara, M., Szymusiak, R. and McGinty, D. (2009) Role of adenosine A(1) receptor in the perifornical-lateral hypothalamic area in sleep-wake regulation in rats. Brain Res. 1304, 96-104.
  3. Baranwal, N., Yu, P. K. and Siegel, N. S. (2023) Sleep physiology, pathophysiology, and sleep hygiene. Prog. Cardiovasc. Dis. 77, 59-69.
  4. Bawazeer, S. and Rauf, A. (2021) In vivo anti-inflammatory, analgesic, and sedative studies of the extract and naphthoquinone isolated from Diospyros kaki (persimmon). ACS Omega 6, 9852-9856.
  5. Bermejo, M., Mangas-Sanjuan, V., Gonzalez-Alvarez, I. and Gonzalez-Alvarez, M. (2017) Enhancing oral absorption of β-lapachone: progress till date. Eur. J. Drug Metab. Pharmacokinet. 42, 1-10.
  6. Brown, R. E., Basheer, R., McKenna, J. T., Strecker, R. E. and McCarley, R. W. (2012) Control of sleep and wakefulness. Physiol. Rev. 92, 1087-1187.
  7. Chamberlin, N. L., Arrigoni, E., Chou, T. C., Scammell, T. E., Greene, R. W. and Saper, C. B. (2003) Effects of adenosine on gabaergic synaptic inputs to identified ventrolateral preoptic neurons. Neuroscience 119, 913-918.
  8. Eban-Rothschild, A., Appelbaum, L. and de Lecea, L. (2018) Neuronal mechanisms for sleep/wake regulation and modulatory drive. Neuropsychopharmacology 43, 937-952.
  9. Elmenhorst, D., Basheer, R., McCarley, R. W. and Bauer, A. (2009) Sleep deprivation increases A(1) adenosine receptor density in the rat brain. Brain Res. 1258, 53-58.
  10. Elmenhorst, D., Meyer, P. T., Winz, O. H., Matusch, A., Ermert, J., Coenen, H. H., Basheer, R., Haas, H. L., Zilles, K. and Bauer, A. (2007) Sleep deprivation increases A1 adenosine receptor binding in the human brain: a positron emission tomography study. J. Neurosci. 27, 2410-2415.
  11. Garrido-Suarez, B. B., Garrido-Valdes, M. and Garrido, G. (2022) Reactogenic sleepiness after COVID-19 vaccination. A hypothesis involving orexinergic system linked to inflammatory signals. Sleep Med. 98, 79-86.
  12. Gomes, C. L., de Albuquerque Wanderley Sales, V., Gomes de Melo, C., Ferreira da Silva, R. M., Vicente Nishimura, R. H., Rolim, L. A. and Rolim Neto, P. J. (2021) Beta-lapachone: natural occurrence, physicochemical properties, biological activities, toxicity and synthesis. Phytochemistry 186, 112713.
  13. Horner, R. L. and Peever, J. H. (2017) Brain circuitry controlling sleep and wakefulness. Continuum (Minneap. Minn.) 23, 955-972.
  14. Huang, L., Zhu, W., Li, N., Zhang, B., Dai, W., Li, S. and Xu, H. (2024) Functions and mechanisms of adenosine and its receptors in sleep regulation. Sleep Med. 115, 210-217.
  15. Imeri, L. and Opp, M. R. (2009) How (and why) the immune system makes us sleep. Nat. Rev. Neurosci. 10, 199-210.
  16. Jamwal, S., Mittal, A., Kumar, P., Alhayani, D. M. and Al-Aboudi, A. (2019) Therapeutic potential of agonists and antagonists of A1, A2a, A2b and A3 adenosine receptors. Curr. Pharm. Des. 25, 2892-2905.
  17. Lee, E. J., Ko, H. M., Jeong, Y. H., Park, E. M. and Kim, H. S. (2015) β-Lapachone suppresses neuroinflammation by modulating the expression of cytokines and matrix metalloproteinases in activated microglia. J. Neuroinflammation 12, 133.
  18. Lee, K. B., Latif, S. and Kang, Y. S. (2023) Differences in neurotransmitters level as biomarker on sleep effects in dementia patients with insomnia after essential oils treatment. Biomol. Ther. (Seoul) 31, 298-305.
  19. Li, Y., Feng, M., Guo, T., Wang, Z. and Zhao, Y. (2023) Tailored beta-lapachone nanomedicines for cancer-specific therapy. Adv. Healthcare Mater. 12, 2300349.
  20. Liu, Y. J., Chen, J., Li, X., Zhou, X., Hu, Y. M., Chu, S. F., Peng, Y. and Chen, N. H. (2019) Research progress on adenosine in central nervous system diseases. CNS Neurosci. Ther. 25, 899-910.
  21. Mikhail, C., Vaucher, A., Jimenez, S. and Tafti, M. (2017) ERK signaling pathway regulates sleep duration through activity-induced gene expression during wakefulness. Sci. Signal. 10, eaai9219.
  22. Morairty, S., Rainnie, D., McCarley, R. and Greene, R. (2004) Disinhibition of ventrolateral preoptic area sleep-active neurons by adenosine: a new mechanism for sleep promotion. Neuroscience 123, 451-457.
  23. Oh, J., Petersen, C., Walsh, C. M., Bittencourt, J. C., Neylan, T. C. and Grinberg, L. T. (2019) The role of co-neurotransmitters in sleep and wake regulation. Mol. Psychiatry 24, 1284-1295.
  24. Park, J. S., Leem, Y. H., Park, J. E., Kim, D. Y. and Kim, H. S. (2019) Neuroprotective effect of β-Lapachone in MPTP-induced Parkinson's disease mouse model: involvement of astroglial p-AMPK/Nrf2/HO-1 signaling pathways. Biomol. Ther. (Seoul) 27, 178-184.
  25. Rauf, A., Abu-Izneid, T., Alhumaydhi, F. A., Muhammad, N., Aljohani, A. S. M., Naz, S., Bawazeer, S., Wadood, A. and Mubarak, M. S. (2020) In vivo analgesic, anti-inflammatory, and sedative activity and a molecular docking study of dinaphthodiospyrol G isolated from Diospyros lotus. BMC Complement. Med. Ther. 20, 237.
  26. Sachdeva, S. and Gupta, M. (2013) Adenosine and its receptors as therapeutic targets: an overview. Saudi Pharm. J. 21, 245-253.
  27. Saddichha, S. (2010) Diagnosis and treatment of chronic insomnia. Ann. Indian Acad. Neurol. 13, 94-102.
  28. Saper, C. B. and Fuller, P. M. (2017) Wake-sleep circuitry: an overview. Curr. Opin. Neurobiol. 44, 186-192.
  29. Scammell, T. E., Arrigoni, E. and Lipton, J. O. (2017) Neural circuitry of wakefulness and sleep. Neuron 93, 747-765.
  30. Sheth, S., Brito, R., Mukherjea, D., Rybak, L. P. and Ramkumar, V. (2014) Adenosine receptors: expression, function and regulation. Int. J. Mol. Sci. 15, 2024-2052.
  31. Silvers, M. A., Deja, S., Singh, N., Egnatchik, R. A., Sudderth, J., Luo, X., Beg, M. S., Burgess, S. C., DeBerardinis, R. J., Boothman, D. A. and Merritt, M. E. (2017) The NQO1 bioactivatable drug, β-lapachone, alters the redox state of NQO1+ pancreatic cancer cells, causing perturbation in central carbon metabolism. J. Biol. Chem. 292, 18203-18216.
  32. Spanoghe, J., Larsen, L. E., Craey, E., Manzella, S., Van Dycke, A., Boon, P. and Raedt, R. (2020) The signaling pathways involved in the anticonvulsive effects of the adenosine A(1) receptor. Int. J. Mol. Sci. 22, 320.
  33. Strecker, R. E., Morairty, S., Thakkar, M. M., Porkka-Heiskanen, T., Basheer, R., Dauphin, L. J., Rainnie, D. G., Portas, C. M., Greene, R. W. and McCarley, R. W. (2000) Adenosinergic modulation of basal forebrain and preoptic/anterior hypothalamic neuronal activity in the control of behavioral state. Behav. Brain Res. 115, 183-204.
  34. Thakkar, M. M., Delgiacco, R. A., Strecker, R. E. and McCarley, R. W. (2003) Adenosinergic inhibition of basal forebrain wakefulness-active neurons: a simultaneous unit recording and microdialysis study in freely behaving cats. Neuroscience 122, 1107-1113.
  35. Thakkar, M. M., Engemann, S. C., Walsh, K. M. and Sahota, P. K. (2008) Adenosine and the homeostatic control of sleep: effects of A1 receptor blockade in the perifornical lateral hypothalamus on sleep-wakefulness. Neuroscience 153, 875-880.
  36. Thakkar, M. M., Winston, S. and McCarley, R. W. (2002) Orexin neurons of the hypothalamus express adenosine A1 receptors. Brain Res. 944, 190-194.
  37. Trinh, N. H. P. (2021) Coincident Modulation of Adenosine Receptor and Metabotropic Glutamate Receptor 5. Monash University.
  38. Trinh, P. N. H., Baltos, J. A., Hellyer, S. D., May, L. T. and Gregory, K. J. (2022) Adenosine receptor signalling in Alzheimer's disease. Purinergic Signal. 18, 359-381.
  39. Um, S., Jeong, H., An, J. S., Jo, S. J., Kim, Y. R., Oh, D. C. and Moon, K. (2023) Chromatographic determination of the absolute configuration in sanjoinine A that increases nitric oxide production. Biomol. Ther. (Seoul) 31, 566-572.
  40. Van Dort, C. J., Baghdoyan, H. A. and Lydic, R. (2009) Adenosine A(1) and A(2A) receptors in mouse prefrontal cortex modulate acetylcholine release and behavioral arousal. J. Neurosci. 29, 871-881.
  41. Wang, Y. Q., Zhang, M. Q., Li, R., Qu, W. M. and Huang, Z. L. (2018) The mutual interaction between sleep and epilepsy on the neurobiological basis and therapy. Curr. Neuropharmacol. 16, 5-16.
  42. Winkelman, J. W. (2015) Insomnia disorder. N. Engl. J. Med. 373, 1437-1444.